"Injecting clean or being clean?" The International and Israeli experiences of Syringe Exchange Programs among injecting drugs users

Harefuah

Volumn 147, Issue 7, 2008, Pages 634-638

  Chemtob, Daniel ^a,b   Levit, Shabtai ^a   Mell, Haim ^c   Margolis, Anatoly ^b   Levy, Avi ^a,b   Leventhal, Alex ^b  

^a MINISTRY OF HEALTH   (Israel)

^b MOH   (Israel)

^c Israel Anti Drug Authority   (Israel)

Author keywords

AIDS; Harm reduction; HIV; Injecting drug users; Syringe exchange program

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADDICTION; BLOODBORNE BACTERIUM; DISEASE TRANSMISSION; HUMAN; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; REVIEW; SUBSTANCE ABUSE; SYRINGE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD-BORNE PATHOGENS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; SYRINGES;

EID: 53849133118     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. World Health Organization. Evidence for action: Effectiveness of drug dependence treatment in prevention of HIV among injecting drug users. Department of HIV/AIDS Prevention & Department of substance abuse, Geneva, Switzerland, 2004.
2. Galai N, Safaeian M, Bolotin A & Celentano D, Longitudinal patterns of drug injection behavior in the ALIVE study cohort, 1988-2000: description and determinants. Am J Epidemiol, 2003; 158: 695-704.
3. Gibson D, Flynn M & Perales D, Effective of syringe exchange program in reducing HIV risk behavior and HIV seroconversion among injection drug users. AIDS, 2001; 15: 1329-1341.
4. Teichman M, Life in a different world: Alcohol, drugs, and human behavior. Ramot Edition, Tel Aviv, 1989 (in Hebrew).
5. Frank H, Leventhal A, The concept "addiction" has past its usefulness for sometimes now. In: Hovav M, (Ed) Treatment and Rehabilitation of Drug Abusers in Israel: Development, Current Status and Issues. Chercover Ed., Tel Aviv, 2002, pp. 279-93, (In Hebrew).
6. Levit S, The relationships between background characteristics and treatment input and the retention and abstinence rates in the Jerusalem methadone program. Jerusalem. Master Thesis in Social Work, Hebrew University, Jerusalem, 1999 (In Hebrew).
7. Levit S, Benlevy A & Kelgkopf M, Methadone and other agonist treatment. In: Hovav M, (Ed.). Treatment and Rehabilitation of Drug Abusers in Israel: Development, Current Status and Issues. Chercover Ed., Tel Aviv, 2002, pp. 75-89 (in Hebrew).
8. Marlett GA, Harm reduction: come as you are. Addict Behav, 1996; 21: 779-788.
9. Miller N & Chappel J, History of the disease concept. Psychiatric Annals, 1991; 21: 196-205.
10. Riley PD & Sawka E, Harm reduction: concepts and practice. A policy discussion paper. Substance Use & Misuse, 1999; 34: 9-24.
11. Erickson PG, Introduction: the three phases of harm reduction, an examination of emerging concepts, methodologies, and critics. Substance Use & Misuse, 1999; 34: 1-9.
12. Yuet W & Cheung PD, Previous participation in outpatient methadone program and residential treatment outcome: a research note from Hong Kong. Substance Use & Misuse, 1999; 34: 103-118.
13. Simpson DD & Sells BS, Opioid Addiction and Treatment: a 12-Year Follow-Up (Ed). Robert E. Kriger Publishing Company, Florida, 1990.
14. Berridge V, Histories of Harm Reduction: Illicit Drugs, Tobacco, and Nicotine. Substance Use & Misuse, 1999; 34: 35-47.
15. Erickson PG, Harm reduction: what it is and is not? Drug Alcohol Rev, 1995; 14: 283-285.
16. Caulkins JP & Reuter P, Setting goals for drug policy: harm reduction or use reduction? Addiction, 1997; 92: 1143-1150.
17. Single E, Defining Harm Reduction. Drug Alcohol Rev, 1995; 14: 287-290.
18. Strang J, Drug Use and Harm Reduction: Responding To the Challenge. (Ed) Whurr, London, 1993.
19. Cameron T & Wild PD, Compulsory substance-user treatment and harm reduction: a critical analysis. Substance Use & Misuse, 1999; 34: 83-102.
20. World Health Organization/UNAIDS/UN Office Drugs and Crime. Evidence for action on HIV/AIDS and injecting drug use. Policy brief: antiretroviral therapy and injecting drug users, 2005.
21. European Center for the Epidemiological Monitoring of HIV/AIDS Surveillance in Europe, 2006, No.73.
22. Rhodes T, Mikhailova L, Sarang A & al, Situational factors influencing drug injecting, risk reduction and syringe in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med, 2003; 57: 39-54.
23. World Health Organization/UNAIDS/UN Office Drugs and Crime. Evidence for action on HIV/AIDS and injecting drug use. Policy brief: antiretroviral therapy and injecting drug users, 2005.
24. Chemlob D, HIV/AIDS in Israel - Epidemiological Periodical Report, 1981-2005. Department of Tuberculosis and AIDS, Public Health Services, Ministry of Health, Jerusalem, 2006
25. Isralowitz R, Toward an understanding of Russian speaking heroin addicts and drug treatment services in Israel. J S Pract Add, 2001; 2: 33-44.
26. Amirkhanian YA, Kelly JA & McAuliffe TL, Psychosocial needs, mental health and HIV transmission risk behavior among people living with HIV/AIDS in St. Petersburg, Russia. AIDS, 2003; 17: 2367-2374.
27. Ksobiech K, Beyond needle sharing: Meta-Analyses of social context risk behavior of injection drug users attending needle exchange program. Sub Use & Misuse, 2006; 41: 1379-1394.
28. Des Jarlais D, Perlis T, Arasteh K & al, HIV incidence among injection drug users in New York city, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. Am J Pub Health, 2005: 95: 1439-44.
29. Hagan H, Mc gough JP & Thiede H, Volunteer bias in nonrandomized evaluation of the efficacy of needle exchange program. J Urban Health, 2000; 77: 103-112.
30. Persons J, Hickman M, Turnbull PJ & al, Over a decade of syringe exchange: results from 1997 UK survey. Addiction, 2000; 97: 845-850.
31. Marx MA, Crape B, Brookmeyer RS & al, Trends in crime and the introduction of a needle exchange program. J Pub Health, 2000; 90: 1933-1936.
32. Isralowitz R & Borkin S, Russian-speaking immigrants: factors associated with heroin use. In: People in Transition, 2001, pp 89-112.
33. Chemtob D & Grossman Z, The epidemiology of adult and adolescent HIV infection in Israel, a country of immigration. Int J STD AIDS, 2004; 15: 691-696.
34. Chemtob D, Epidemiology of HIV/AIDS among Intravenous Drug Users in Israel, 1983-1999. International Conference of the International Society of Addiction Medicine (ISAM), Tel Aviv, 2001: 81.
35. th National Conference on Health Education and Promotion in Israel, Jerusalem, November 2006: 29 (In Hebrew).